Ya-Wei Yuan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ya-Wei Yuan has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Ai-Min Sun
Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province 510515, China
2 shared publicationsQuan-Quan Sun
Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
2 shared publicationsYing Liu
2 shared publications- Ai-Min Sun
Department of Radiotherapy, Zhujiang Hospital, First Military Medical University, Guangzhou 510282, China
1 shared publication Chen Ren
1 shared publicationChuan-Gang Li
1 shared publication
Latest Publications
- 1 April 2011
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 236 (4) , 418-422
STAT1 promotes radioresistance of CD44+/CD24−/low cells in breast cancer
Breast cancer-initiating cells are a relatively radioresistant subpopulation of breast cancer cells. However, the mechanism of this radioresistance is still unclear. This study aimed to investigate the effect of radiation on the levels of signal transducer and activator of transcription 1 (STAT1) in mammospheres of cancer-initiating cells and monolayer cultures of MCF-7 cells. We isolated CD44+/CD24−/low cancer-initiating cells from MCF-7 cells and propagated them as mammospheres. Next we used realtime quantitative reverse-transcriptase polymerase chain reaction to examine the mRNA level of STAT1 in mammospheres of breast cancer-initiating cells and monolayer cultures of MCF-7 cells. The apoptosis rate and surviving fraction using clonogenic assays was observed after treating the cells with a STAT1 inhibitor. After irradiation, the STAT1 level in the mammospheres was higher than that in the monolayer cultures. STAT1 inhibitor treatment did not cause significant changes in the apoptosis rate and surviving fraction in the MCF-7 monolayer cultures. However, the inhibitor treatment caused significant differences in the apoptosis rate and surviving fraction in mammospheres. Our study provides the first evidence that STAT1 signaling contributes to radioresistance in breast cancer-initiating cells and reveals STAT1 as a promising target to reduce radioresistance and enhance the efficacy of radiotherapy for breast cancer.
- 1 April 2011
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 236 (4) , 418-422
STAT1 promotes radioresistance of CD44+/CD24−/low cells in breast cancer
Breast cancer-initiating cells are a relatively radioresistant subpopulation of breast cancer cells. However, the mechanism of this radioresistance is still unclear. This study aimed to investigate the effect of radiation on the levels of signal transducer and activator of transcription 1 (STAT1) in mammospheres of cancer-initiating cells and monolayer cultures of MCF-7 cells. We isolated CD44+/CD24−/low cancer-initiating cells from MCF-7 cells and propagated them as mammospheres. Next we used realtime quantitative reverse-transcriptase polymerase chain reaction to examine the mRNA level of STAT1 in mammospheres of breast cancer-initiating cells and monolayer cultures of MCF-7 cells. The apoptosis rate and surviving fraction using clonogenic assays was observed after treating the cells with a STAT1 inhibitor. After irradiation, the STAT1 level in the mammospheres was higher than that in the monolayer cultures. STAT1 inhibitor treatment did not cause significant changes in the apoptosis rate and surviving fraction in the MCF-7 monolayer cultures. However, the inhibitor treatment caused significant differences in the apoptosis rate and surviving fraction in mammospheres. Our study provides the first evidence that STAT1 signaling contributes to radioresistance in breast cancer-initiating cells and reveals STAT1 as a promising target to reduce radioresistance and enhance the efficacy of radiotherapy for breast cancer.
- 1 April 2011
- Vol. 31 (4) , 599-603
[Effect of shRNAmir lentiviral vector-mediated COX-2 silencing on the radiosensitivity of nasopharyngeal carcinoma cells].
To evaluate the effect of COX-2 silencing on the radiosensitivity of a nasopharyngeal carcinoma (NPC) cell line C666-1. Anti-COX-2 C666-1 cell line with COX-2 gene silencing mediated by shRNAmir lentiviral vector and the control cell line Anti-GL-2 C666-1 were exposed to various radiation doses. The clonogenic survival assay and curve fitting was used to calculate the radiobiological parameters and the sensitization enhancement ratio after the radiation. Cell cycle changes were assessed after the exposure by flow cytometric analysis. In a BALB/c nude mouse model, the growth curve of the xenografts was generated and the tumor growth inhibition rate was calculated. Compared with the control cells, Anti-COX-2 C666-1 cells showed obviously lowered values of SF2, D0 and Dq but significantly increased α/β with a sensitivity enhancement ratio of 1.4014. COX-2 gene silencing increased the inhibition rate of the tumor xenografts after the radiation, and caused also decreased percentage of G2/M arrest resulting from the exposure. Stable COX-2 silencing in NPC cells can improve the effect of radiotherapy both in vitro and in vivo. By changing the radiobiological parameters, genetically based COX-2 inhibitor may be a potentially promising radiosensitizer of NPC.
- 1 April 2011
- Vol. 31 (4) , 599-603
[Effect of shRNAmir lentiviral vector-mediated COX-2 silencing on the radiosensitivity of nasopharyngeal carcinoma cells].
To evaluate the effect of COX-2 silencing on the radiosensitivity of a nasopharyngeal carcinoma (NPC) cell line C666-1. Anti-COX-2 C666-1 cell line with COX-2 gene silencing mediated by shRNAmir lentiviral vector and the control cell line Anti-GL-2 C666-1 were exposed to various radiation doses. The clonogenic survival assay and curve fitting was used to calculate the radiobiological parameters and the sensitization enhancement ratio after the radiation. Cell cycle changes were assessed after the exposure by flow cytometric analysis. In a BALB/c nude mouse model, the growth curve of the xenografts was generated and the tumor growth inhibition rate was calculated. Compared with the control cells, Anti-COX-2 C666-1 cells showed obviously lowered values of SF2, D0 and Dq but significantly increased α/β with a sensitivity enhancement ratio of 1.4014. COX-2 gene silencing increased the inhibition rate of the tumor xenografts after the radiation, and caused also decreased percentage of G2/M arrest resulting from the exposure. Stable COX-2 silencing in NPC cells can improve the effect of radiotherapy both in vitro and in vivo. By changing the radiobiological parameters, genetically based COX-2 inhibitor may be a potentially promising radiosensitizer of NPC.
- 1 January 2011
- Vol. 31 (1) , 53-6
[Radiation-induced G2 phase arrest may contribute to the radioresistance of breast cancer stem cells].
To investigate radiation-induced cell cycle changes of human breast cancer stem cells enriched by suspension culture. The tumorigenicity of human breast cancer stem cell line MCF-7 cultured in serum-free media was confirmed in NOD/SCID mice, and the radiosensitivity of the cells was tested by clone formation assay following radiation exposure. Flow cytometry was performed to evaluate radiation-induced cell cycle changes, and the protein expression of pCDC25C (ser216) was measured by Western blotting. After the exposure to 2 Gy radiation, the survived fraction of the cells in suspension culture and those in adherent culture was 0.856 ∓ 0.061 and 0.783 ∓ 0.097, respectively, and the cells in suspension culture showed an obviously greater capacity of tumorigenicity in NOD/SCID mice. The radiation exposure resulted in an obvious increase in the proportion of G2 phase cells from (22.03 ∓ 2.12)% to (45.83 ∓ 2.25)% and significantly increased the expression of pCDC25C (ser216). Radiation- induced G2 phase arrest may contribute to the resistance of the breast cancer stem cells to radiotherapy.
- 1 January 2011
- Vol. 31 (1) , 53-6
[Radiation-induced G2 phase arrest may contribute to the radioresistance of breast cancer stem cells].
To investigate radiation-induced cell cycle changes of human breast cancer stem cells enriched by suspension culture. The tumorigenicity of human breast cancer stem cell line MCF-7 cultured in serum-free media was confirmed in NOD/SCID mice, and the radiosensitivity of the cells was tested by clone formation assay following radiation exposure. Flow cytometry was performed to evaluate radiation-induced cell cycle changes, and the protein expression of pCDC25C (ser216) was measured by Western blotting. After the exposure to 2 Gy radiation, the survived fraction of the cells in suspension culture and those in adherent culture was 0.856 ∓ 0.061 and 0.783 ∓ 0.097, respectively, and the cells in suspension culture showed an obviously greater capacity of tumorigenicity in NOD/SCID mice. The radiation exposure resulted in an obvious increase in the proportion of G2 phase cells from (22.03 ∓ 2.12)% to (45.83 ∓ 2.25)% and significantly increased the expression of pCDC25C (ser216). Radiation- induced G2 phase arrest may contribute to the resistance of the breast cancer stem cells to radiotherapy.
- 1 February 2002
- Vol. 22 (2) , 121-3
[Correlation of protein kinase C activity and its subcellular distrubution with multidrug resistance in KVB200 cells].
To investigate the relationship between protein kinase C (PKC) and multidrug resistance (MDR) in cancer cell line KBV200. MTT assay was used to evaluate the IC50 of vincristine (VCR) and adriamycin (ADR) in KB cell line and its VCR-resistant derivative KBV200 cells. PKC activities in the 2 cell lines were assayed by measuring the incorporation of (32)P from [gamma-(32)P] ATP into the peptide substrates. The IC50 values of VCR and ADR in KBV200 cells was 64.03 and 18.8 folds greater than those in KB cells. PKC activities of the membrane and cytosol fraction in KBV200 cells were increased compared with that in KB cells, with the total PKC activity 1.12-fold higher. Phorbol-12-myristate-13 -acetate increased PKC activity of the membrane fraction and IC50 values of KBV200 cells, while staurosporine worked to the opposite effects. PKC may contribute to MDR mechanism in KBV200 cells.
- 1 February 2002
- Vol. 22 (2) , 121-3
[Correlation of protein kinase C activity and its subcellular distrubution with multidrug resistance in KVB200 cells].
To investigate the relationship between protein kinase C (PKC) and multidrug resistance (MDR) in cancer cell line KBV200. MTT assay was used to evaluate the IC50 of vincristine (VCR) and adriamycin (ADR) in KB cell line and its VCR-resistant derivative KBV200 cells. PKC activities in the 2 cell lines were assayed by measuring the incorporation of (32)P from [gamma-(32)P] ATP into the peptide substrates. The IC50 values of VCR and ADR in KBV200 cells was 64.03 and 18.8 folds greater than those in KB cells. PKC activities of the membrane and cytosol fraction in KBV200 cells were increased compared with that in KB cells, with the total PKC activity 1.12-fold higher. Phorbol-12-myristate-13 -acetate increased PKC activity of the membrane fraction and IC50 values of KBV200 cells, while staurosporine worked to the opposite effects. PKC may contribute to MDR mechanism in KBV200 cells.